BI 695501 (Cyltezo®; adalimumab-adbm) in rheumatoid arthritis - VJBM

$ 21.50

4.9 (270) In stock

This video discusses the clinical equivalence of BI 695501 (Cyltezo®; adalimumab-adbm) and adalimumab for rheumatoid arthritis - the VOLTAIRE-RA and extension studies.

Rheumatology Dosing & Administration

Cyltezo (adalimumab): Uses, Side Effects, Dosage & Reviews

Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE- RA equivalence study

Sam Cavana on LinkedIn: The effects of palovarotene in patients with fibrodysplasia ossificans…

Cyltezo (adalimumab): Uses, Side Effects, Dosage & Reviews

Cyltezo (adalimumab): Uses, Side Effects, Dosage & Reviews

Evidence for Rheumatoid Arthritis

Evidence for Crohn's Disease

Cyltezo (adalimumab): Uses, Side Effects, Dosage & Reviews

Uveitis Cyltezo® (adalimumab-adbm)